Susquehanna Fundamental Investments, LLC Cor Medix Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $119,273 - $190,142	-26,743 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$6.05 - $10.09 $16,595 - $27,676	2,743 Added 11.43%	26,743 $183,000
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $55,500 - $101,565	11,100 Added 86.05%	24,000 $178,000
Q3 2020 Nov 16, 2020	BUY	$3.96 - $6.15 $51,084 - $79,335	12,900 New	12,900 $78,000

105

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $353M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.